Opinion
přijatá stanoviska on 10/06/2009
Odkaz:
INT/469-EESC-2009-1022Referral:
COM(2008) 663 final - 2008/0256 (COD)Rapporteur:
Plenární zasedání:
454 -
Jun 10, 2009 Jun 11, 2009
Farmaceutické výrobky
Displaying 21 - 27 of 27
Pages
Opinion
přijatá stanoviska on 10/06/2009
Odkaz:
INT/471-EESC-2009-1024Referral:
COM(2008) 665 final – 2008/0260 (COD)Rapporteur:
Plenární zasedání:
454 -
Jun 10, 2009 Jun 11, 2009
Opinion
přijatá stanoviska on 10/06/2009
Odkaz:
INT/470-EESC-2009-1023Referral:
COM(2008) 664 final – 2008/0257 (COD)Rapporteur:
Ms Sylvia Gauci (Employers - GR I / Malta)
Plenární zasedání:
454 -
Jun 10, 2009 Jun 11, 2009
Opinion
přijatá stanoviska on 10/06/2009
Odkaz:
INT/475-EESC-2009-1025Referral:
COM(2008) 662 final - 2008/0255 (COD)Rapporteur:
Plenární zasedání:
454 -
Jun 10, 2009 Jun 11, 2009
Opinion
Odkaz:
ECO/515-EESC-2020-01536-00-01-PAC-TRA Referral:
COM(2020) 113 final 2020/0043 CODGeneral Rapporteur:
Bernd SCHLÜTER (Diversity Europe - GR III)
Downloads:
Publication
28 pages
On 31 March 2022, the European Economic and Social Committee (EESC) held a high-level conference on Health challenges in the EU in the pandemic context.
Published in:
2022
Publication
8 pages
Following the publication of the European Commission's Update to the New Industrial Strategy, the European Economic and Social Committee (EESC) has been carrying out a series of activities to fulfil its role of representing the views of organised civil society. A key event in this process has been a conference held on 17 June 2021, from 2.30 to 6 p.m., on Updated industrial strategy: towards a more resilient and strategically autonomous EU industry.
Published in:
2021